Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Retatrutide may become an option in the future if: Its approved by the MHRA and recommended by NICE, which is likely several years away You havent responded well to existing GLP-1 medications, and a triple agonist offers a different approach worth trying The Phase 3 safety data on heart rate, irregular heartbeats, and dysesthesia are reassuring once its complete For most people in the UK, the choice now is between Wegovy and Mounjaro, supported by a structured weight management service
Jones O, Jurascheck L, van Melle M, et al
Making it part of a routine can make it easier to remember
Confirm KPV Mass and sequence evidence should match Lys-Pro-Val and identify the declared salt form
US$ 26.50
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)
US$ 22.84
US$ 24.01
US$ 24.61
US$ 24.28
US$ 26.71
